We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/8/2022 16:06 | Subject to a successful sale of business outcome, we anticipate that there would be a dividend to unsecured creditors, however, the quantum is currently unknown. | neilyb675 | |
04/8/2022 16:04 | Talk about running on empty Upon appointment, the Company held funds of GBP0.3 million and $7.1 million Anyway Whatever they get, after Oxford Administrators Tax man Staff There probably won't be anything for us poor plebs. | katsy | |
04/8/2022 16:02 | Sale of business As alluded to above, we commenced a sale of business process shortly after appointment. We have contacted nearly fifty large pharmaceutical businesses and smaller biotechnology companies (including other prominent players in the microbiome space). Due to the commercial sensitivity of this sales process, we can only provide limited narrative as to the exact progress to date. Offer deadlines have been set with all interested parties and the details of indicative offers received cannot be disclosed subject to confidentiality agreement provisions. Alongside the above sale of business activity, we continue to explore the possibility of a refinance of the Group and an exit from administration. Similarly to above, progress here is confidential and updates will be made available to creditors at the appropriate time. Should no viable offers emerge during the sale of business process, our strategy will likely be to minimise costs to preserve the Company's main asset, floating charge cash, and realise the Company's other assets. | neilyb675 | |
04/8/2022 15:56 | OF have allowed money to be paid towards trials as well ...Which is a glimmer of hope .. | amaretto1 | |
04/8/2022 15:54 | Not sure what to think ...It looks like they may be some hope Like i said a few weeks back Keytruda drug | amaretto1 | |
04/8/2022 15:49 | DDDD Administrator's Proposals - "we commenced a sale of business process shortly after appointment. We have contacted nearly fifty large pharmaceutical businesses and smaller biotechnology companies (including other prominent players in the microbiome space). Due to the commercial sensitivity of this sales process, we can only provide limited narrative as to the exact progress to date. Offer deadlines have been set with all interested parties and the details of indicative offers received cannot be disclosed subject to confidentiality agreement provisions. Alongside the above sale of business activity, we continue to explore the possibility of a refinance of the Group and an exit from administration. Similarly to above, progress here is confidential and updates will be made available to creditors at the appropriate time. Should no viable offers emerge during the sale of business process, our strategy will likely be to minimise costs to preserve the Company's main asset, floating charge cash, and realise the Company's other assets." Guess who makes the most out of this! "From the date of our appointment to 28 July 2022, we have incurred time costs of £580,488. These represent 876.65 hours at an average rate of £662.12 per hour." Bargain? | napoleon 14th | |
04/8/2022 15:48 | Very interesting RNS | amaretto1 | |
04/8/2022 15:41 | RNS out:4d Pharma PLC - Publication of Joint Administrators' Proposals #DDDD https://www.voxmarke | lostsole | |
29/7/2022 16:00 | Got that as well Katsy, had to look twice as I thought it was one I had missed from weeks back. | machinist | |
27/7/2022 13:21 | Nothing new from what I can see. Looks dire. | nigelpm | |
24/7/2022 09:33 | No recent update that I can detect ...Anyone ...? | lostsole | |
23/7/2022 09:54 | Telegram group look at STX thread !! | amaretto1 | |
18/7/2022 15:30 | Good to hear! | one_frankel | |
18/7/2022 15:02 | It pays to be red pilled. For instance I knew to avoid all the pharma's in the race to develop covid therapeutics as I knew nothing would be allowed to get in the way of the covid jabs. I traded them on the excitement but I didn't hang around to find out the results of the trials because I knew they would be made to fail. I take your point though | katsy | |
18/7/2022 14:17 | You need to be careful with reading too much into those type of articles Katsy, they'll play tricks on your mind when trading/investing and its won't be productive to yourself in the monetary sense either! | one_frankel | |
16/7/2022 14:03 | Noone was blindsided as it was stated in no uncertain terms a year earlier but if the companies too shortsighted to leave it until the very last moment then you have to adhere to the consequences that follow... And FatGreek, if you live by the sword then unfortunately you have to die by it too but a lesson no doubt not to catch a falling knife as the market is rarely wrong regardless of what one believes! | one_frankel | |
15/7/2022 20:15 | 4D board do seem stupid beyong logic, a bit like Tony Manini at ARS although I would accuse the later of being a leach whereas 4D had a lot of skin in the game. | napoleon 14th | |
15/7/2022 13:02 | I think the management were completely blind sided by Oxford pulling the rug. When they approached them 23rd/24th June about not being able to make payment I am sure they naively assumed that Oxford would make some accommodation for their position and allow time to explore fundraising options. | machinist | |
15/7/2022 10:45 | I see AGL managed to raise GBP20M today. So begs the question just how useless were the bod. Or was the new CFO placed there by Oxford to ensure they went bust. | katsy | |
15/7/2022 08:14 | Quite obvious it was engineered. If you are as despereate as 4D were to raise funds, you just do a primary bid raise and get the money you need at whatever price, just to secure your survival. | liam1om |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions